GSK840 (GSK-840) is a novel and potent receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor with an IC50 of 0.3 nM. Receptor-interacting protein kinase 3 (RIP3 or RIPK3) has emerged as a central player in necroptosis and a potential target to control inflammatory disease.

纯度：≥98%

CAS：2361146-30-5